True cut gun semi automatic (Bard) (DC) at Dr. Essa Lab

True cut gun semi automatic (Bard) (DC) at Dr. Essa Lab

Core needle biopsy (CNB) represents a cornerstone of modern diagnostic oncology and pathology. The True cut gun semi automatic (Bard) (DC) is a highly specialized medical instrument designed to obtain high-quality, un-fragmented tissue core samples from deep or superficial lesions. Unlike fine-needle aspiration (FNA), which only harvests individual cells or small cell clusters, a core needle biopsy using the semi-automatic Bard Tru-Cut gun retrieves a solid cylinder of tissue. This preserves the histological architecture of the tissue, allowing pathologists to evaluate the spatial relationship of cells, the stromal background, and vascular invasion. This structural preservation is absolutely critical for accurate tumor grading, subtyping, and performing advanced ancillary testing such as immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and molecular genetic profiling.

At Dr. Essa Lab, this advanced diagnostic procedure is performed under the guidance of highly experienced interventional radiologists and pathologists. The use of the semi-automatic Bard biopsy gun ensures exceptional precision, safety, and patient comfort. The instrument features a dual-stage mechanism: a specimen notch that is manually or semi-automatically advanced into the target tissue, followed by a spring-loaded outer cutting cannula that rapidly shears the tissue core. This rapid cutting action minimizes tissue displacement, reduces patient discomfort, and consistently yields high-quality specimens that are essential for definitive diagnosis. This procedure is invaluable for evaluating lesions in the breast, lymph nodes, liver, kidneys, and soft tissues, providing a clear diagnostic pathway without the need for major surgical intervention.

Clinical Procedure: What to Expect

Patient Preparation

• Coagulation Profile Assessment: Patients must undergo a baseline coagulation profile, including Prothrombin Time (PT), International Normalized Ratio (INR), Activated Partial Thromboplastin Time (APTT), and a complete blood count (CBC) to assess platelet levels. This minimizes the risk of post-procedural hemorrhage.
• Medication Review: Patients must inform the clinical team of all medications they are currently taking. Anticoagulants and antiplatelet agents (such as aspirin, warfarin, clopidogrel, or newer oral anticoagulants) must typically be discontinued 5 to 7 days prior to the procedure, strictly under the guidance of their prescribing physician.
• Fasting Guidelines: For superficial biopsies (such as breast or peripheral lymph nodes), fasting is generally not required. However, for deep-seated organ biopsies (such as liver or kidney) or if conscious sedation is planned, patients are advised to fast (nil by mouth) for 4 to 6 hours before the procedure.
• Review of Prior Imaging: Patients must bring all relevant previous imaging studies, including ultrasounds, CT scans, mammograms, or MRI reports, to help the radiologist precisely localize the lesion.
• Informed Consent: A detailed explanation of the procedure, its benefits, and potential risks (such as localized bleeding, bruising, or mild discomfort) will be provided, and written informed consent will be obtained.
• Comfortable Attire: Patients should wear loose, comfortable clothing and avoid wearing jewelry or metallic accessories near the biopsy site.

During the Procedure

The patient is positioned comfortably on the examination table. The exact position depends on the target site; for example, supine or slightly turned for a breast biopsy, supine for a liver biopsy, or prone for a kidney biopsy. The skin overlying the target area is thoroughly cleansed with an antiseptic solution (such as chlorhexidine or povidone-iodine) and draped with sterile towels to maintain a completely aseptic environment. A local anesthetic (typically 1% or 2% lidocaine) is injected into the skin and subcutaneous tissues along the planned needle tract. This numbs the area completely, ensuring the patient feels minimal to no pain during the procedure.

The interventional radiologist uses real-time imaging (most commonly high-resolution ultrasound, though CT guidance may be used for deeper thoracic or abdominal lesions) to visualize the lesion and plan the safest trajectory for the biopsy needle. A tiny skin incision (approximately 2-3 mm) is made to facilitate the entry of the Bard semi-automatic Tru-Cut needle. Under continuous imaging guidance, the needle is advanced to the edge of the lesion. The semi-automatic mechanism is activated, producing a distinct clicking sound as the cutting cannula shears the tissue core. The needle is carefully withdrawn, and the intact tissue core is retrieved from the specimen notch. The sample is immediately inspected for adequacy and placed in a vial containing 10% neutral buffered formalin for transport to the histopathology laboratory. Typically, 2 to 4 passes are performed to ensure a representative sample is obtained. Once the biopsy is complete, firm manual pressure is applied to the site for 10 to 15 minutes to prevent hematoma formation, followed by a sterile dressing. The patient is monitored in a recovery area for 30 to 60 minutes to ensure hemodynamic stability and the absence of immediate complications before being safely discharged.

When is a True cut gun semi automatic (Bard) (DC) Performed?

Evaluation of Suspicious Breast Masses

This procedure is highly indicated when clinical breast examinations or imaging modalities (such as mammography or breast ultrasound) reveal suspicious lesions classified as BI-RADS 4 or 5. It allows for the definitive differentiation between benign conditions like fibroadenomas and malignant conditions like invasive ductal carcinoma, guiding subsequent surgical and oncological planning.

Investigation of Persistent Lymphadenopathy

When patients present with unexplained, persistent enlargement of cervical, axillary, or inguinal lymph nodes, a core needle biopsy is essential. It provides intact tissue architecture necessary to distinguish between reactive hyperplasia, infectious etiologies (such as tuberculosis), lymphoma, or metastatic deposits from a primary malignancy elsewhere in the body.

Diagnosis of Soft Tissue Tumors

Deep-seated or superficial soft tissue masses in the extremities, trunk, or retroperitoneum require histological evaluation. The Bard semi-automatic Tru-Cut biopsy provides high-quality tissue cores that enable pathologists to differentiate benign lipomas or leiomyomas from highly aggressive sarcomas, ensuring accurate grading and staging.

Assessment of Solid Organ Lesions (Liver or Kidney)

For patients with focal liver lesions or renal masses detected on abdominal imaging, a core biopsy is performed to establish a definitive diagnosis. It helps identify primary malignancies like hepatocellular carcinoma (HCC) or renal cell carcinoma (RCC), benign lesions, or diffuse parenchymal diseases like cirrhosis or glomerulonephritis.

Characterization of Unexplained Nodules or Masses

Physicians request this biopsy for any unexplained nodular lesions or masses in the head and neck, musculoskeletal system, or pelvic regions. The procedure provides the critical histopathological evidence required to formulate targeted therapeutic strategies, avoiding the need for more invasive open surgical biopsies.

What Does a True cut gun semi automatic (Bard) (DC) Detect?

The True cut gun semi automatic (Bard) (DC) biopsy is capable of detecting a wide range of benign, pre-malignant, and malignant conditions across various anatomical sites. Key clinical findings include:

• Invasive Ductal Carcinoma (IDC) of the breast
• Invasive Lobular Carcinoma (ILC) of the breast
• Ductal Carcinoma In Situ (DCIS)
• Fibroadenoma (benign breast tumor)
• Fibrocystic breast changes
• Hodgkin Lymphoma (nodular sclerosis or mixed cellularity)
• Non-Hodgkin Lymphoma (such as Diffuse Large B-Cell Lymphoma)
• Metastatic adenocarcinoma in regional lymph nodes
• Reactive follicular hyperplasia of lymph nodes
• Granulomatous lymphadenitis (suggestive of Tuberculosis or Sarcoidosis)
• Hepatocellular Carcinoma (HCC) of the liver
• Cholangiocarcinoma (bile duct cancer)
• Hepatic steatosis (fatty liver disease)
• Cirrhosis and advanced liver fibrosis
• Renal Cell Carcinoma (RCC) of the kidney
• Oncocytoma (benign renal tumor)
• Glomerulonephritis and nephrotic parenchymal changes
• Liposarcoma (malignant soft tissue tumor)
• Benign lipoma
• Leiomyosarcoma (smooth muscle malignancy)
• Leiomyoma (benign smooth muscle tumor)
• Schwannoma or neurofibroma (nerve sheath tumors)
• Nodular fasciitis (benign reactive lesion)
• Chronic granulomatous mastitis
• Fat necrosis of the breast or soft tissues
• Acute suppurative inflammation or abscess formation
• Myxoid liposarcoma
• Synovial sarcoma
• Atypical ductal hyperplasia (ADH)
• Phyllodes tumor of the breast

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that waiting for biopsy results can be an anxious time for patients and their families. The histopathological processing of tissue cores obtained via the True cut gun semi automatic (Bard) (DC) is a meticulous multi-step process. This includes tissue fixation, dehydration, paraffin embedding, microtome sectioning, hematoxylin and eosin (H&E) staining, and detailed microscopic evaluation by our board-certified consultant pathologists. Typically, the standard turnaround time for a histopathology report is 3 to 5 working days. In complex cases where advanced ancillary testing—such as immunohistochemistry (IHC) or special histochemical stains—is required to determine the exact tumor subtype or origin, an additional 2 to 3 days may be necessary. Dr. Essa Lab provides seamless and convenient access to diagnostic reports. Patients can easily access and download their verified reports online through the official Dr. Essa Lab website or via the dedicated mobile application. Additionally, reports can be collected directly from any of our conveniently located diagnostic centers across Pakistan, or received via automated WhatsApp notifications, ensuring timely clinical decision-making.

True cut gun semi automatic (Bard) (DC) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Breast Tissue	Normal lobules, ducts, and specialized stroma without atypia	Invasive ductal/lobular carcinoma, DCIS, fibroadenoma
Lymph Nodes	Preserved nodal architecture with normal germinal centers	Lymphoma, metastatic carcinoma, granulomatous tuberculosis
Liver Parenchyma	Normal lobular architecture, hepatocytes, and portal tracts	Hepatocellular carcinoma, steatohepatitis, cirrhosis
Kidney Parenchyma	Normal glomeruli, tubules, interstitium, and blood vessels	Renal cell carcinoma, glomerulonephritis, amyloidosis
Soft Tissue Mass	Normal skeletal muscle, adipose tissue, or fibrous stroma	Liposarcoma, leiomyosarcoma, fibromatosis, schwannoma
Cellular Morphology	Uniform cell size, normal nuclear-to-cytoplasmic ratio	Anaplasia, nuclear pleomorphism, atypical mitotic figures
Stromal Background	Normal collagenous or myxoid stroma without infiltration	Desmoplastic reaction, tumor necrosis, amyloid deposition
Vascular Structures	Normal blood vessels without thrombosis or invasion	Angiogenesis, tumor emboli, microvascular invasion

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for True cut gun semi automatic (Bard) (DC)?

• Experienced healthcare professionals
• Patient-focused care
• Quality diagnostic services
• Professional reporting
• Modern diagnostic approach
• Comfortable environment
• Convenient location
• Commitment to accurate diagnosis